A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
- 1 February 2019
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 164, 366-377
Abstract
No abstract availableKeywords
Funding Information
- Polish Science Centre (2016/23/D/ST5/00242)
- Foundation For Polish Science
This publication has 181 references indexed in Scilit:
- Salinomycin induces apoptosis and senescence in breast cancer: Upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylationBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Monensin A acid complexes as a model of electrogenic transport of sodium cationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2012
- Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPKTumor Biology, 2012
- Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cellsInternational Journal of Cancer, 2012
- A Late‐Stage Intermediate in Salinomycin Biosynthesis Is Revealed by Specific Mutation in the Biosynthetic Gene ClusterChemBioChem, 2011
- Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarizationBiochemical and Biophysical Research Communications, 2011
- Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrestInvestigational New Drugs, 2011
- Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cellsBiochemical and Biophysical Research Communications, 2010
- Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cellsBiochemical and Biophysical Research Communications, 2009
- ABC Transporters, Drug Resistance, and Cancer Stem CellsJournal of Mammary Gland Biology and Neoplasia, 2009